High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study
- 8 August 2010
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 102 (3) , 433-442
Abstract
We conducted a phase II study to test methotrexate (5 g/m2), as a single agent prior to radiochemotherapy for pediatric high-grade glioma and diffuse intrinsic pontine glioma. Thirty patients (19 male, median age 10.8) were enrolled. Tumors were located as follows: cortex 10, pons 7, other 13. Tumor resection was classified as gross total in 6, subtotal in 6, partial in 4, biopsy in 11 and not performed in 3. WHO grading of the histology was: IV: 11, III: 12 and II: 3. Patients received methotrexate 5 g/m2 in 24-hour infusions on days 1 and 15. Subsequently 54 Gy radiation was administered with simultaneous chemotherapy including cisplatin, etoposide, vincristine and ifosfamide as previously described. Eight 6-weeks cycles of maintenance chemotherapy consisted of vincristine 1.5 mg/m2 on days 1, 8 and 15; lomustine 100 mg/m2 on day 2 and prednisone 40 mg/kg on days 1–17. Event-free survival rates in the whole group of 30 patients were: 43, 20, and 13% after 1, 2 and 5 years, respectively. The response evaluation after methotrexate was available in 19 of the 24 patients who started treatment with measurable disease: CR: 0, PR: 1, SD 18, PD: 0. After radiochemotherapy the response of 24 patients with measurable disease was CR: 1, PR 10, SD 12, PD 1. Both response and event-free survival were superior to the control group of 330 patients treated in various protocols of the same cooperative group. In subgroup analyses the use of dexamethasone during early treatment was linked to poor event free survival. Giving two cycles of high-dose methotrexate prior to radiochemotherapy was feasible, and the approach was taken forward to a randomized phase III trial.Keywords
This publication has 38 references indexed in Scilit:
- Intensive chemotherapy improves survival in pediatric high‐grade glioma after gross total resection: results of the HIT‐GBM‐C protocolCancer, 2009
- Prediction of tumour regrowth of pontine glioma using a two-term model.2008
- Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM databaseJournal of Neuro-Oncology, 2008
- Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphomaNeurology, 2007
- LATE RESPONSE TO RADIOCHEMOTHERAPY IN PEDIATRIC GLIOBLASTOMA: Report on Two Patients Treated According to HIT-GBM ProtocolsPediatric Hematology and Oncology, 2006
- Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study.2003
- Synchronous radiochemotherapy in unfavorable brain tumors of children and young adultsJournal of Neuro-Oncology, 1998
- HIT-GBM: Multizentrische Studie zur Behandlung von Kindern mit malignen GliomenKlinische Padiatrie, 1996
- Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells.1996
- Magnetic Resonance Scans Should Replace Biopsies for the Diagnosis of Diffuse Brain Stem GliomasNeurosurgery, 1993